Quest Diagnostics
DGX
#1132
Rank
$16.36 B
Marketcap
$147.35
Share price
0.92%
Change (1 day)
2.31%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - Cash on Hand

Cash on Hand as of March 2024 : $0.47 B

According to Quest Diagnostics 's latest financial reports the company has $0.47 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Quest Diagnostics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.68 B117.78%
2022-12-31$0.31 B-63.88%
2021-12-31$0.87 B-24.7%
2020-12-31$1.15 B-2.85%
2019-12-31$1.19 B782.96%
2018-12-31$0.13 B-1.46%
2017-12-31$0.13 B-61.84%
2016-12-31$0.35 B169.92%
2015-12-31$0.13 B-30.73%
2014-12-31$0.19 B2.67%
2013-12-31$0.18 B-36.82%
2012-12-31$0.29 B79.52%
2011-12-31$0.16 B-63.3%
2010-12-31$0.44 B-15.9%
2009-12-31$0.53 B110.38%
2008-12-31$0.25 B51.52%
2007-12-31$0.16 B12%
2006-12-31$0.14 B62.42%
2005-12-31$92.13 M25.69%
2004-12-31$73.3 M-52.7%
2003-12-31$0.15 B60.12%
2002-12-31$96.77 M-20.89%
2001-12-31$0.12 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$99.3 M-79.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.42 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.38 B-18.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$57.15 M-87.94%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$0.89 B 88.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands